nCVTs : a hybrid smart tumour targeting platform
A hybrid drug delivery platform involving the fusion of cell membranes from U937 monocytes and synthetic lipids to create nano-cell vesicle technology systems (nCVTs) is designed. nCVTs are engineered for a targeted approach towards tumour sites by preserving key surface proteins from U937 monocytes...
Saved in:
Main Authors: | Goh, Wei Jiang, Zou, Shui, Czarny, Bertrand, Pastorin, Giorgia |
---|---|
Other Authors: | School of Materials Science and Engineering |
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/141157 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
DEVELOPMENT OF NANO-CELL VESICLE TECHNOLOGY SYSEM (nCVTs) FOR CANCER THERAPY
by: OU YI HSUAN
Published: (2021) -
Targeting tumours by adoptive transfer of immune cells
by: MacAry, P.A., et al.
Published: (2011) -
Glomus tumour of the musculoskeletal system
by: Hee, H.T., et al.
Published: (2012) -
Glomus tumour of the musculoskeletal system
by: Hee, H.T., et al.
Published: (2016) -
HUT: Hybrid UNet Transformer for brain lesion and tumour segmentation
by: Soh, Wei Kwek, et al.
Published: (2024)